국가 또는 지역을 선택하십시오


South Africa

EN

Canada

FR EN

México

ES EN

United States

EN

Australia

EN

China / 中国

ZH EN

India

EN

South Korea / 대한민국

KO EN

Malaysia

EN

Singapore

EN

Taiwan / 台灣

ZH EN

Thailand

TH EN

Vietnam

VI EN

Česká Republika

CS EN

Danmark

DA EN

Deutschland

DE EN

España

ES EN

France

FR EN

Ireland

EN

Österreich

DE EN

Polska

PL EN

Schweiz / Suisse / Svizzera

DE FR IT EN

Sweden

SV EN

Netherlands

NL EN

Norway

EN

Global

EN

제안을 받으려면 입력을 시작하세요.

검색 제안

제안을로드하는 중


제품 제안

제안을로드하는 중


제품 분석에 실패에 대한 마진은 없습니다.

Customer and task

A leading medtech company must be able to count on Bossard. Devices for medical diagnostics require mechanical components that operate with the utmost precision.

Solution

The initial bolt procured through Bossard ensures ultra-precise centering of the needle for pipetting reagents from the various cartridges. Reagents are agents that can identify a substance in the blood. The bolt is used to configure the position of the draw-off needle before the analysis run.

The engineered product is part of a blood analyzer for clinical chemistry and immunology in labs. The machine is used to analyze just a few specimens or to perform several hundred tests per hour, depending on the model.

 

Two of the many parts that Bossard procures for its client. To the left, the initial bolt. To the right, the part that secures the position of the motor on the analysis module. Due to high temperatures in the analysis module, these parts are made of high-precision steel.

Customer benefits

The customer has taken advantage of Bossard’s C-parts management service for several of its devices. Bossard coordinates about 120 suppliers of engineered products and saves the diagnostic solution provider the need to process 4,000 to 5,000 orders per year, including incoming goods inspections.

Because of its experience with C-parts management, Bossard has become this customer’s preferred partner. The customer indicated that choosing Bossard had been the best decision it could have made. It is already considering expanding its collaboration, says the managing buyer.